Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise Post ContentmlysRead More You might also be interested in reading John Lewis sniffs out success with perfumes. May 13, 2025 In Mainstream ← Previous post Next post →